CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint BlockadeGuangchuan Wang, Sidi Chen, Kristin Kim et al.|Cancer Discovery|2020Cited by 143